Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that 24 month visual acuity results from patients ...
Additional analysis of visual acuity loss, genotypic profiles, and retinal imaging data from a 24-month Phase 2 trial of ...
Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, ...
For busy moms, maintaining eye health amidst a hectic schedule can seem challenging, but incorporating quick and effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results